Literature DB >> 11281242

Low-dose combination therapy: an important first-line treatment in the management of hypertension.

J M Neutel1, D H Smith, M A Weber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281242     DOI: 10.1016/s0895-7061(00)01310-8

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  14 in total

Review 1.  Is fixed combination therapy appropriate for initial hypertension treatment?

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

2.  Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study).

Authors:  Masatoshi Fujita; Shigetake Sasayama; Fumio Terasaki; Satoko Mitani; Tatsuya Morimoto; Tsutomu Yamazaki; Doubun Hayashi; Takahide Kohro; Yoshihiro Okada; Ryozo Nagai
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

3.  How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).

Authors:  Andrea L Schaffer; Sallie-Anne Pearson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

4.  Actual practice in hypertension: implications for persistence with and effectiveness of therapy.

Authors:  J D Spence; T C Hurley; J D Spence
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 5.  Fixed low-dose combination therapy for hypertension.

Authors:  Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

6.  The expectant model of hypertension management: setting expectations to achieve blood pressure control--applying a business principle to hypertension management.

Authors:  Michael A Moore
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738

Review 7.  Emerging insights in the first-step use of antihypertensive combination therapy.

Authors:  Keith Norris; Joel M Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

Review 8.  Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies.

Authors:  C Ventika S Ram
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

9.  Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension.

Authors:  Christina M Salerno; Laura Demopoulos; Robin Mukherjee; Alan H Gradman
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-11       Impact factor: 3.738

10.  The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

Authors:  Jonathan C Fox; Kellie Leight; Santosh C Sutradhar; Laura A Demopoulos; Gilbert W Gleim; Andrew J Lewin; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.